Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Future Oncology (London, England)|June 17, 2020
Unscheduled hydrations: redefining complete response in chemotherapy-induced nausea and vomiting studiesRudolph M Navari, Eric J Roeland
Expert Opinion on Emerging Drugs|March 1, 2006
Emerging drugs for chemotherapy-induced emesisRudolph M Navari, Paula S Province
Oncotargets and Therapy|October 17, 2018
Evolving role of neurokinin 1-receptor antagonists for chemotherapy-induced nausea and vomitingRudolph M Navari, Lee S Schwartzberg
Advances in Therapy|May 26, 2018
Safety of Polysorbate 80 in the Oncology SettingLee S Schwartzberg, Rudolph M Navari
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 17, 2009
Treatment of cancer-related anorexia with olanzapine and megestrol acetate: a randomized trialRudolph M Navari, Marie C Brenner
The Journal of Supportive Oncology|October 26, 2011
Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a randomized phase III trialRudolph M Navari, Sarah E Gray, Andrew C Kerr
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 15, 2013
The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapyRudolph M Navari, Cindy K Nagy, Sarah E Gray
Breast Cancer Research and Treatment|December 8, 2007
Treatment of depressive symptoms in patients with early stage breast cancer undergoing adjuvant therapyRudolph M Navari, Marie C Brenner, Megan N Wilson
Clinical Advances in Hematology & Oncology : H&O|May 31, 2014
Clinical roundtable monograph: New data in emerging treatment options for chemotherapy-induced nausea and vomitingGary R Morrow, Rudolph M Navari, Hope S Rugo
Pageof 8